PL1735321T3 - Proces wytwarzania 42-estrów rapamycyny i 32-estrów FK-506 z kwasem dikarboksylowym, prekursory koniugatów rapamycyny oraz przeciwciała - Google Patents

Proces wytwarzania 42-estrów rapamycyny i 32-estrów FK-506 z kwasem dikarboksylowym, prekursory koniugatów rapamycyny oraz przeciwciała

Info

Publication number: PL1735321T3
Authority: PL; Poland
Prior art keywords: esters; rapamycin; dicarboxylic acid; precursors; antibodies
Prior art date: 2004-04-14

Application number

PL05735488T

Other languages

English (en)

Inventor

Jianxin Gu

Ping Cai

Mark E Ruppen

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-14

Filing date

2005-04-12

Publication date

2009-04-30

2005-04-12 Application filed by Wyeth Corp filed Critical Wyeth Corp

2009-04-30 Publication of PL1735321T3 publication Critical patent/PL1735321T3/pl

Links

ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 title abstract 4
QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 title abstract 4
229960002930 sirolimus Drugs 0.000 title abstract 4
OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 title abstract 2
238000004519 manufacturing process Methods 0.000 title 1
239000002243 precursor Substances 0.000 title 1
238000000034 method Methods 0.000 abstract 2
102000004882 Lipase Human genes 0.000 abstract 1
108090001060 Lipase Proteins 0.000 abstract 1
239000004367 Lipase Substances 0.000 abstract 1
150000008064 anhydrides Chemical class 0.000 abstract 1
230000001588 bifunctional effect Effects 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
238000006243 chemical reaction Methods 0.000 abstract 1
150000001991 dicarboxylic acids Chemical class 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
235000019421 lipase Nutrition 0.000 abstract 1
238000003786 synthesis reaction Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Wood Science & Technology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Health & Medical Sciences (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

PL05735488T 2004-04-14 2005-04-12 Proces wytwarzania 42-estrów rapamycyny i 32-estrów FK-506 z kwasem dikarboksylowym, prekursory koniugatów rapamycyny oraz przeciwciała PL1735321T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US56196604P	2004-04-14	2004-04-14
EP05735488A EP1735321B1 (en)	2004-04-14	2005-04-12	Process for preparing rapamycin 42-esters and fk-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies
PCT/US2005/012268 WO2005105812A1 (en)	2004-04-14	2005-04-12	Process for preparing rapamycin 42-esters and fk-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies

Publications (1)

Publication Number	Publication Date
PL1735321T3 true PL1735321T3 (pl)	2009-04-30

Family

ID=34965703

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05735488T PL1735321T3 (pl)	2004-04-14	2005-04-12	Proces wytwarzania 42-estrów rapamycyny i 32-estrów FK-506 z kwasem dikarboksylowym, prekursory koniugatów rapamycyny oraz przeciwciała

Country Status (14)

Country	Link
US (2)	US7445916B2 (pl)
EP (1)	EP1735321B1 (pl)
JP (1)	JP2007532655A (pl)
CN (1)	CN1942478A (pl)
AT (1)	ATE410431T1 (pl)
AU (1)	AU2005238432A1 (pl)
BR (1)	BRPI0509810A (pl)
CA (1)	CA2562962A1 (pl)
DE (1)	DE602005010228D1 (pl)
DK (1)	DK1735321T3 (pl)
ES (1)	ES2313328T3 (pl)
MX (1)	MXPA06011882A (pl)
PL (1)	PL1735321T3 (pl)
WO (1)	WO2005105812A1 (pl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2344821C2 (ru) *	2002-07-30	2009-01-27	Уайт	Парентеральные композиции, содержащие гидроксиэфиры рапамицина
PL1735321T3 (pl) *	2004-04-14	2009-04-30	Wyeth Corp	Proces wytwarzania 42-estrów rapamycyny i 32-estrów FK-506 z kwasem dikarboksylowym, prekursory koniugatów rapamycyny oraz przeciwciała
CN1946852A (zh) *	2004-04-27	2007-04-11	惠氏公司	利用雷帕霉素特异性甲基化酶标记雷帕霉素
TW200616633A (en) *	2004-08-10	2006-06-01	Wyeth Corp	CCI-779 derivatives and methods of making same
PE20070748A1 (es) *	2005-12-07	2007-08-08	Wyeth Corp	Proceso ajustable a escala para la preparacion de un 42-ester de rapamicina a partir de un boronato de 42-ester de rapamicina
AR058282A1 (es) *	2005-12-07	2008-01-30	Wyeth Corp	Forma cristalina purificada de cci-779, un proceso para la preparacion del mismo, un metodo para monitorear la cristalizacion del cci-779, un kit y una composicion farmaceutica que lo comprenden y su uso en la fabricacion de un medicamento para el tratamiento del cancer.
JP2009518648A (ja) *	2005-12-07	2009-05-07	ワイス	結晶性ラパマイシンを調製するための方法およびを示差走査熱量測定使用してラパマイシン化合物の結晶化度を測定するための方法
CA2644156A1 (en)	2006-03-07	2007-09-13	Wyeth	Process for preparing water-soluble polyethylene glycol conjugates of macrolide immunosuppressants
US8022188B2 (en) *	2006-04-24	2011-09-20	Abbott Laboratories	Immunosuppressant binding antibodies and methods of obtaining and using same
US9700704B2 (en)	2006-11-20	2017-07-11	Lutonix, Inc.	Drug releasing coatings for balloon catheters
US8414525B2 (en)	2006-11-20	2013-04-09	Lutonix, Inc.	Drug releasing coatings for medical devices
US20080276935A1 (en)	2006-11-20	2008-11-13	Lixiao Wang	Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
US8430055B2 (en)	2008-08-29	2013-04-30	Lutonix, Inc.	Methods and apparatuses for coating balloon catheters
US8998846B2 (en)	2006-11-20	2015-04-07	Lutonix, Inc.	Drug releasing coatings for balloon catheters
US9737640B2 (en)	2006-11-20	2017-08-22	Lutonix, Inc.	Drug releasing coatings for medical devices
US8414909B2 (en)	2006-11-20	2013-04-09	Lutonix, Inc.	Drug releasing coatings for medical devices
US8414526B2 (en)	2006-11-20	2013-04-09	Lutonix, Inc.	Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
US8425459B2 (en)	2006-11-20	2013-04-23	Lutonix, Inc.	Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
US8414910B2 (en)	2006-11-20	2013-04-09	Lutonix, Inc.	Drug releasing coatings for medical devices
TW200845960A (en) *	2007-04-05	2008-12-01	Wyeth Corp	Wortmannin-rapalog conjugate and uses thereof
CA2937492C (en)	2008-11-11	2019-08-13	The Board Of Regents Of The University Of Texas System	Inhibition of mammalian target of rapamycin
US10391059B2 (en)	2009-11-11	2019-08-27	Rapamycin Holdings, Inc.	Oral rapamycin nanoparticle preparations and use
US9283211B1 (en)	2009-11-11	2016-03-15	Rapamycin Holdings, Llc	Oral rapamycin preparation and use for stomatitis
PT2885007T (pt)	2012-08-16	2018-12-10	Pfizer	Processos e composições de glicoconjugação
US20160030401A1 (en)	2013-03-13	2016-02-04	The Board Of Regents Of The University Of Texas System	Use of mtor inhibitors for prevention of intestinal polyp growth and cancer
US9700544B2 (en)	2013-12-31	2017-07-11	Neal K Vail	Oral rapamycin nanoparticle preparations
EP3848065B1 (en)	2017-05-15	2023-07-26	C. R. Bard, Inc.	Medical device with drug-eluting coating and intermediate layer
JP7262581B2 (ja)	2018-11-14	2023-04-21	ルトニックス，インコーポレーテッド	改質されたデバイス表面に薬物溶出コーティングを有する医療用デバイス
CN113939324A (zh)	2019-04-08	2022-01-14	巴德外周血管股份有限公司	在经改性装置表面上具有药物洗脱涂层的医疗装置
CN118027062B (zh) *	2023-11-03	2025-02-14	沈阳药科大学	一种雷帕霉素前药及其纳米制剂的制备和应用
GB202415232D0 (en)	2024-10-16	2024-11-27	Nacamed As	Composition

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA737247B (en)	1972-09-29	1975-04-30	Ayerst Mckenna & Harrison	Rapamycin and process of preparation
US4316885A (en) *	1980-08-25	1982-02-23	Ayerst, Mckenna And Harrison, Inc.	Acyl derivatives of rapamycin
US4650803A (en) *	1985-12-06	1987-03-17	University Of Kansas	Prodrugs of rapamycin
US5210030A (en) *	1990-06-25	1993-05-11	Merck & Co., Inc.	Process for selectively acylating immunomycin
US5023264A (en) *	1990-07-16	1991-06-11	American Home Products Corporation	Rapamycin oximes
PT98990A (pt) *	1990-09-19	1992-08-31	American Home Prod	Processo para a preparacao de esteres de acidos carboxilicos de rapamicina
US5130307A (en) *	1990-09-28	1992-07-14	American Home Products Corporation	Aminoesters of rapamycin
US5221670A (en) *	1990-09-19	1993-06-22	American Home Products Corporation	Rapamycin esters
US5378696A (en) *	1990-09-19	1995-01-03	American Home Products Corporation	Rapamycin esters
US5233036A (en) *	1990-10-16	1993-08-03	American Home Products Corporation	Rapamycin alkoxyesters
US5080899A (en)	1991-02-22	1992-01-14	American Home Products Corporation	Method of treating pulmonary inflammation
US5078999A (en)	1991-02-22	1992-01-07	American Home Products Corporation	Method of treating systemic lupus erythematosus
US5120842A (en)	1991-04-01	1992-06-09	American Home Products Corporation	Silyl ethers of rapamycin
US5100883A (en)	1991-04-08	1992-03-31	American Home Products Corporation	Fluorinated esters of rapamycin
US5118678A (en) *	1991-04-17	1992-06-02	American Home Products Corporation	Carbamates of rapamycin
US5118667A (en)	1991-05-03	1992-06-02	Celtrix Pharmaceuticals, Inc.	Bone growth factors and inhibitors of bone resorption for promoting bone formation
US5130507A (en) *	1991-05-23	1992-07-14	Eaton Corporation	Capacitive switch assembly
DE69209183T2 (de)	1991-06-18	1996-08-08	American Home Prod	Verwendung von Rapamycin zur Behandlung von T-Zellen Lymphom/Leukämie bei Erwachsenen
US5162333A (en) *	1991-09-11	1992-11-10	American Home Products Corporation	Aminodiesters of rapamycin
US5177203A (en) *	1992-03-05	1993-01-05	American Home Products Corporation	Rapamycin 42-sulfonates and 42-(N-carboalkoxy) sulfamates useful as immunosuppressive agents
US5256790A (en) *	1992-08-13	1993-10-26	American Home Products Corporation	27-hydroxyrapamycin and derivatives thereof
GB9221220D0 (en) *	1992-10-09	1992-11-25	Sandoz Ag	Organic componds
US5411967A (en) *	1992-10-13	1995-05-02	American Home Products Corporation	Carbamates of rapamycin
US5434260A (en) *	1992-10-13	1995-07-18	American Home Products Corporation	Carbamates of rapamycin
US5480989A (en) *	1992-10-13	1996-01-02	American Home Products Corporation	Carbamates of rapamycin
US5489680A (en) *	1992-10-13	1996-02-06	American Home Products Corporation	Carbamates of rapamycin
US5302584A (en) *	1992-10-13	1994-04-12	American Home Products Corporation	Carbamates of rapamycin
US5480988A (en) *	1992-10-13	1996-01-02	American Home Products Corporation	Carbamates of rapamycin
US5262423A (en) *	1992-10-29	1993-11-16	American Home Products Corporation	Rapamycin arylcarbonyl and alkoxycarbonyl carbamates as immunosuppressive and antifungal agents
US5258389A (en) *	1992-11-09	1993-11-02	Merck & Co., Inc.	O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives
US5260300A (en) *	1992-11-19	1993-11-09	American Home Products Corporation	Rapamycin carbonate esters as immuno-suppressant agents
US5252579A (en) *	1993-02-16	1993-10-12	American Home Products Corporation	Macrocyclic immunomodulators
GB9307491D0 (en) *	1993-04-08	1993-06-02	Sandoz Ltd	Organic compounds
EP1181938B1 (en) *	1993-04-23	2007-11-14	Wyeth	Rapamycin conjugates and antibodies
US5504091A (en) *	1993-04-23	1996-04-02	American Home Products Corporation	Biotin esters of rapamycin
WO1994025072A1 (en)	1993-04-23	1994-11-10	American Home Products Corporation	Rapamycin conjugates and antibodies
GB2281294A (en) *	1993-08-23	1995-03-01	Fujisawa Pharmaceutical Co	Process for producing half esters of the macrolide FK506
US5378836A (en) *	1993-10-08	1995-01-03	American Home Products Corporation	Rapamycin oximes and hydrazones
US5391730A (en) *	1993-10-08	1995-02-21	American Home Products Corporation	Phosphorylcarbamates of rapamycin and oxime derivatives thereof
US5373014A (en) *	1993-10-08	1994-12-13	American Home Products Corporation	Rapamycin oximes
US5385910A (en) *	1993-11-22	1995-01-31	American Home Products Corporation	Gem-distributed esters of rapamycin
US5385908A (en) *	1993-11-22	1995-01-31	American Home Products Corporation	Hindered esters of rapamycin
US5385909A (en) *	1993-11-22	1995-01-31	American Home Products Corporation	Heterocyclic esters of rapamycin
US5389639A (en) *	1993-12-29	1995-02-14	American Home Products Company	Amino alkanoic esters of rapamycin
US5362718A (en)	1994-04-18	1994-11-08	American Home Products Corporation	Rapamycin hydroxyesters
US5463048A (en) *	1994-06-14	1995-10-31	American Home Products Corporation	Rapamycin amidino carbamates
US5491231A (en) *	1994-11-28	1996-02-13	American Home Products Corporation	Hindered N-oxide esters of rapamycin
US5563145A (en) *	1994-12-07	1996-10-08	American Home Products Corporation	Rapamycin 42-oximes and hydroxylamines
US6261813B1 (en) *	1995-09-11	2001-07-17	Albany Molecular Research, Inc.	Two step enzymatic acylation
US5780462A (en) *	1995-12-27	1998-07-14	American Home Products Corporation	Water soluble rapamycin esters
EP0973805A1 (en)	1997-04-09	2000-01-26	Isotechnika, Inc.	Method for production of antibodies to specific sites of rapamycin
US6277983B1 (en)	2000-09-27	2001-08-21	American Home Products Corporation	Regioselective synthesis of rapamycin derivatives
US7153983B2 (en) *	2002-03-25	2006-12-26	Council Of Scientific And Industrial Research	Chemo-enzymatic process for the preparation of opticaly enriched β-benzyl-γ-butyrolactones
US6745478B2 (en)	2002-07-18	2004-06-08	Delillo Dominick D.	Multi-purpose work knife
JP4227649B2 (ja)	2003-08-07	2009-02-18	ワイス	Ｃｃｉ−７７９の位置選択的合成
KR20070015544A (ko) *	2004-04-14	2007-02-05	와이어쓰	라파마이신 42-에스테르 유도체의 위치특이성 합성
PL1735321T3 (pl)	2004-04-14	2009-04-30	Wyeth Corp	Proces wytwarzania 42-estrów rapamycyny i 32-estrów FK-506 z kwasem dikarboksylowym, prekursory koniugatów rapamycyny oraz przeciwciała
EP1751168A1 (en)	2004-04-14	2007-02-14	Wyeth	Proline cci-779 (proline-rapamycin 42-ester with 2,2-bis (hydroxymethyl) propionic acid) and two-step enzymatic synthesis of proline cci-779 and cci-779 using microbial lipase
WO2006004803A1 (en) *	2004-06-30	2006-01-12	Combinatorx, Incorporated	Methods and reagents for the treatment of metabolic disorders

2005
- 2005-04-12 PL PL05735488T patent/PL1735321T3/pl unknown
- 2005-04-12 AU AU2005238432A patent/AU2005238432A1/en not_active Withdrawn
- 2005-04-12 WO PCT/US2005/012268 patent/WO2005105812A1/en not_active Ceased
- 2005-04-12 ES ES05735488T patent/ES2313328T3/es not_active Expired - Lifetime
- 2005-04-12 MX MXPA06011882A patent/MXPA06011882A/es active IP Right Grant
- 2005-04-12 JP JP2007508443A patent/JP2007532655A/ja not_active Withdrawn
- 2005-04-12 EP EP05735488A patent/EP1735321B1/en not_active Expired - Lifetime
- 2005-04-12 DE DE602005010228T patent/DE602005010228D1/de not_active Expired - Fee Related
- 2005-04-12 CN CNA200580011299XA patent/CN1942478A/zh not_active Withdrawn
- 2005-04-12 AT AT05735488T patent/ATE410431T1/de not_active IP Right Cessation
- 2005-04-12 US US11/104,349 patent/US7445916B2/en not_active Expired - Lifetime
- 2005-04-12 BR BRPI0509810-6A patent/BRPI0509810A/pt not_active IP Right Cessation
- 2005-04-12 DK DK05735488T patent/DK1735321T3/da active
- 2005-04-12 CA CA002562962A patent/CA2562962A1/en not_active Abandoned
2008
- 2008-09-29 US US12/240,230 patent/US7625726B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DK1735321T3 (da)	2009-01-12
EP1735321A1 (en)	2006-12-27
ES2313328T3 (es)	2009-03-01
AU2005238432A1 (en)	2005-11-10
CA2562962A1 (en)	2005-11-10
ATE410431T1 (de)	2008-10-15
US20050234087A1 (en)	2005-10-20
MXPA06011882A (es)	2006-12-14
BRPI0509810A (pt)	2007-09-18
DE602005010228D1 (de)	2008-11-20
CN1942478A (zh)	2007-04-04
JP2007532655A (ja)	2007-11-15
US7625726B2 (en)	2009-12-01
US20090029426A1 (en)	2009-01-29
WO2005105812A1 (en)	2005-11-10
EP1735321B1 (en)	2008-10-08
US7445916B2 (en)	2008-11-04

Publication	Publication Date	Title
DK1735321T3 (da)	2009-01-12	Fremgangsmåde til fremstilling af rapamycin 42-estere og FK-506 32-estere med dicarboxylsyre, precursors for rapamycinkonjugater og antistoffer
WO2006078809A3 (en)	2007-07-12	Method for the preparation of maytansinoid esters
WO2003082795A3 (en)	2003-12-24	METHODS OF MANUFACTURING DERIVATIVES OF β-HYDROXYCARBOXYLIC ACIDS
EP1077212A4 (en)	2001-11-21	METHOD FOR PRODUCING VIVIVES OF 6-CYANOMETHYL-1,3-DIOXANE-4-ACETIC ACID
EP1660669A4 (en)	2008-10-01	ENZYMATIC PROCEDURES FOR THE PREPARATION OF 4-SUBSTITUTED 3-HYDROXYBUTYLIC ACID DERIVATIVES AND OF VICINAL CYANO, HYDROXY-SUBSTITUTED CARBOXYLIC ACID ESTERS
EP2348024A3 (en)	2012-04-18	Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
WO2007070609A3 (en)	2007-09-07	Production of peracids using an enzyme having perhydrolysis activity
WO2006000904A3 (en)	2006-04-27	Preparation of pregabalin and related compounds
EP2514828A3 (en)	2013-07-03	Methods for the production of ansamitocins
HUP0402444A2 (en)	2006-11-28	Process for enhancing the biogas production of thermophyl anaerobic fermenter
UA91419C2 (uk)	2010-07-26	Спосіб одержання карбонових кислот і/або їх похідних
WO2007147827A3 (en)	2008-06-12	Production of pravastatin
WO2006058225A8 (en)	2007-06-28	Enzymatic reactions in the presence of keto acids
WO2005105768A3 (en)	2006-03-16	Process for preparation of mycophenolic acid and ester derivatives thereof
WO2007029003A3 (en)	2007-08-16	Method of preparing a hydrogel
Wieczorek et al.	2011	Covalent anchoring of a racemization catalyst to CALB-beads: towards dual immobilization of DKR catalysts
WO2004104205A3 (en)	2005-08-04	Enzymatic preparation of chiral indole esters
Klomp et al.	2005	Enzymatic kinetic resolution of tropic acid
HUP0204173A2 (hu)	2003-03-28	Eljárás konjugált linolénsav előállítására
TW200609211A (en)	2006-03-16	Esterification catalyst and process therewith
TW200609268A (en)	2006-03-16	Composition comprising titanium and clay and process therewith
EP1715480A3 (en)	2009-01-07	Magnetic disk drive
WO2008022627A3 (de)	2008-06-05	Verfahren zur herstellung von optisch aktiven hydroxyalkylacetaten durch racematspaltung von 4-hydr0xy-2-ket0nen unter verwendung von baeyer-vi lliger monooxygenasen
TWI318583B (en)	2009-12-21	Catalyst and process for preparing carboxylic acid esters
Zheng	1997	Photochemical reactions of 2, 3-dihydro-4-pyridones and their application in natural product synthesis: Total synthesis of plumerinine and perhydrohistrionicotoxin.